Top Story

Keratinocyte cancer imposes heavy burden on Dutch population

October 20, 2014

Researchers found keratinocyte cancer has become a large burden in Dutch society, and because incidence rates continue to rise, management has become even more challenging.

Data for all patients with newly diagnosed keratinocyte cancer were obtained from the population-based Netherlands Cancer Registry and the Eindhoven Cancer Registry (1989-2008). The researchers also extracted data on population structure, mortality and life expectancy from Statistics Netherlands. Disability-adjusted life years (DALY) was defined as the sum of the years of life lived with disability and the years of life lost.

figure Meeting News Coverage

Trend toward earlier treatment of uveal melanoma observed

October 17, 2014
CHICAGO — “Despite identification of risk factors, many ophthalmologists still observe borderline lesions, waiting for growth before initiating treatment of…
figure Meeting News Coverage

Nivolumab superior to chemotherapy in metastatic melanoma

October 9, 2014
Nivolumab induced a greater rate of overall response than chemotherapy in patients with metastatic melanoma who progressed on or after anti-CTLA–4 therapy or…

PV-10 well-tolerated in treatment of refractory cutaneous melanoma

October 8, 2014
Intralesional injection of rose bengal disodium was well-tolerated in patients with refractory cutaneous melanoma, with just over half of patients meeting the primary…
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »

Filter By:

figure In the Journals

Keratinocyte cancer imposes heavy burden on Dutch population

October 20, 2014
Researchers found keratinocyte cancer has become a large burden in Dutch society, and because incidence rates continue to rise, management has become…
figure Meeting News Coverage

Trend toward earlier treatment of uveal melanoma observed

October 17, 2014
CHICAGO — “Despite identification of risk factors, many ophthalmologists still observe borderline lesions, waiting for growth before…
figure Meeting News Coverage

Nivolumab superior to chemotherapy in metastatic melanoma

October 9, 2014
Nivolumab induced a greater rate of overall response than chemotherapy in patients with metastatic melanoma who progressed on or after…

PV-10 well-tolerated in treatment of refractory cutaneous melanoma

October 8, 2014
Intralesional injection of rose bengal disodium was well-tolerated in patients with refractory cutaneous melanoma, with just over half of patients…
figure In the Journals

One-third of cancer patients experienced anxiety, mental health disorders

October 6, 2014
About one in three patients with cancer experienced some level of clinically relevant mental health challenge, such as anxiety, depressive disorders…
In the Journals

Melanoma growth rate objectively measured in sequential biopsies

October 2, 2014
Researchers were able to obtain an objective measure of melanoma growth rate by reviewing sequential biopsy specimens from initial misdiagnoses, as…
figure Meeting News Coverage

Cobimetinib plus vemurafenib extended PFS in BRAF V600-mutated metastatic melanoma

September 29, 2014
The addition of cobimetinib to vemurafenib significantly prolonged PFS yet increased toxicity among patients with BRAF V600-mutated melanoma…
In the Journals

Trametinib–dabrafenib combination extended PFS in BRAF-mutated melanoma

September 29, 2014
The addition of trametinib to dabrafenib significantly prolonged PFS in patients with metastatic melanoma who harbored BRAF V600E or V600K
In the Journals

Clinical practice guidelines for melanoma care have room for improvement

September 25, 2014
Adding a dedicated section for the identification, screening and follow-up of people at high risk for melanoma, in addition to providing more clearly…
figure Editorial Publication Exclusive

I’d like to agree with you … but then we’d both be wrong!

HemOnc Today, September 25, 2014
Derek Raghavan, MD, PhD
I sometimes fear that I am a natural curmudgeon, or at the very least a true cynic.If you have read my recent editorials and op-eds, it may seem I…
More Headlines »